SCTB-41
/ Sinocelltech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 16, 2025
Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.
(clinicaltrials.gov)
- P1/2 | N=441 | Recruiting | Sponsor: Sinocelltech Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor
September 20, 2024
Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients With Advanced Malignant Solid Tumours.
(clinicaltrials.gov)
- P1/2 | N=441 | Not yet recruiting | Sponsor: Sinocelltech Ltd.
Metastases • New P1/2 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1